UA116488U - METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION - Google Patents

METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION

Info

Publication number
UA116488U
UA116488U UAU201611951U UAU201611951U UA116488U UA 116488 U UA116488 U UA 116488U UA U201611951 U UAU201611951 U UA U201611951U UA U201611951 U UAU201611951 U UA U201611951U UA 116488 U UA116488 U UA 116488U
Authority
UA
Ukraine
Prior art keywords
persons
behavior
treatment
autodestructive
alcohol cancellation
Prior art date
Application number
UAU201611951U
Other languages
Ukrainian (uk)
Inventor
Ігор Володимирович Лінський
Валерій Никифорович Кузьмінов
Ольга Олександрівна Васильєва
Микола Павлович Юрченко
Володимир Володимирович Задорожний
Анатолій Віталійович Малихін
Original Assignee
Державна Установа "Інститут Неврології, Психіатрії Та Наркології Намн України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Інститут Неврології, Психіатрії Та Наркології Намн України" filed Critical Державна Установа "Інститут Неврології, Психіатрії Та Наркології Намн України"
Priority to UAU201611951U priority Critical patent/UA116488U/en
Publication of UA116488U publication Critical patent/UA116488U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Спосіб лікування аутодеструктивної поведінки у осіб в стані відміни алкоголю за допомогою медикаментозного лікування, причому на фоні традиційної терапії призначають антиконвульсант Депакін (вальпроат натрію) в ін'єкційній формі з розрахунку 25 мг/кг внутрішньовенно струминно один раз на добу.A method of treating self-destructive behavior in persons in a state of alcohol withdrawal with the help of drug treatment, and against the background of traditional therapy prescribe anticonvulsant Depakine (sodium valproate) in injectable form at a rate of 25 mg / kg intravenously once a day.

UAU201611951U 2016-11-25 2016-11-25 METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION UA116488U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201611951U UA116488U (en) 2016-11-25 2016-11-25 METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201611951U UA116488U (en) 2016-11-25 2016-11-25 METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION

Publications (1)

Publication Number Publication Date
UA116488U true UA116488U (en) 2017-05-25

Family

ID=74214386

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201611951U UA116488U (en) 2016-11-25 2016-11-25 METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION

Country Status (1)

Country Link
UA (1) UA116488U (en)

Similar Documents

Publication Publication Date Title
AR106582A1 (en) SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES
PH12020550936A1 (en) Combination drug including tlr7 agonist
MX2021004821A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
MY189466A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
SG10201908697XA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
MX2023012450A (en) Esketamine for the treatment of depression.
CL2011000513A1 (en) Methods for reducing or inhibiting angiogenesis in a subject who has an eye disease or condition associated with angiogenesis that comprises the administration of a tetraspanin 12 antagonist (tspan12) and / or a norrin antagonist.
NI201500150A (en) CANCER TREATMENT WITH DIHYDROPIRAZINE-PIRAZINES × Provided in this method
MX2023000796A (en) Pharmaceutical composition, methods for treating and uses thereof.
MX2021013354A (en) Methods of treating and/or preventing actinic keratosis.
MX2023010064A (en) A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof.
AR111374A1 (en) USE OF LIK066 IN PATIENTS WITH HEART FAILURE
EA201991175A1 (en) THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS
BR112017014914A2 (en) combined therapy for pulmonary hypertension
MX2022003945A (en) Method for treating hiv with cabotegravir and rilpivirine.
UA116488U (en) METHOD OF TREATMENT OF AUTODESTRUCTIVE BEHAVIOR IN PERSONS WITH ALCOHOL CANCELLATION
CO2020000529A2 (en) Methods to treat congenital hyperinsulinism
AR103636A1 (en) METHODS OF TREATMENT OF POSTERPEPTIC NEURALGY WITH A TOPICAL FORMULATION OF AN ESPIRO-OXINDOL COMPOUND
WO2018049003A8 (en) Anti-fibrotic sialidase inhibitor compounds and methods of use
AR102494A1 (en) METHODS TO TREAT EYE DISEASES
WO2019126695A3 (en) Methods and pharmaceutical compositions for treating candida auris in blood
UA108523U (en) METHOD OF TREATMENT OF PATIENTS WITH EARLY AGAINST POSTINCULAR Dementia
UA117786U (en) METHOD OF TREATMENT OF ACUTE ISCHEMIC Stroke
UA116600U (en) METHOD OF TREATMENT OF ACUTE ISCHEMIC STROKE